Alzheimer'S Disease Clinical Trials in Ventura, CA

Alzheimer'S Disease Clinical Trials in Ventura, CA

View the best 10 alzheimer's disease medical studies in Ventura, California. Access promising new therapies by applying to a Ventura-based Alzheimer'S Disease clinical trial.

Trials in Ventura, California

Here are the top 10 medical studies for alzheimer's disease in Ventura, California

Image of Facility #1 in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new drug, lecanemab, to see if it's effective in treating Alzheimer's disease. The trial will last 18 months and have interim analyses to update treatment allocation. Those who complete the trial or discontinue early will be eligible for the Extension Phase, which will last up to 60 months.
Image of North County Neurology Associates in Carlsbad, United States.

Placebo +2 More

Recruiting1 awardPhase 3
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Image of Behavioral Research Specialists, LLC in Glendale, United States.

Placebo +1 More

Recruiting0 awardsPhase 1 & 2
This trial is testing a drug called SNK01 on people with moderate Alzheimer's Disease. The trial wants to know if SNK01 is safe and well-tolerated when given as an infusion every
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Image of MD First Research - Chandler in Chandler, United States.

BMS-986446

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new medication called BMS-986446 in people with early Alzheimer's disease. The medication is designed to target harmful proteins in the brain to slow down the disease. Researchers are checking if it works well and is safe for patients.
Image of University of California San Diego in La Jolla, United States.

Care2Sleep

Behavioural Intervention

Recruiting0 awards5 criteria
This trial tests the Care2Sleep program, which helps people improve their sleep through several educational sessions. It targets pairs of people and caregivers to enhance their sleep, health, and quality of life. The program is available both in-person and online.
Image of Clinical Trial Site in Staten Island, United States.

KarXT +1 More

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing KarXT, a medication, to see if it can prevent psychotic symptoms from returning in people with Alzheimer's Disease. It works by balancing brain chemicals that cause hallucinations and delusions. KarXT has shown positive results in reducing symptoms of schizophrenia.
Image of Novo Nordisk Investigational Site in Lomita, United States.

Semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Image of Clinical Research Site in Phoenix, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Neurological Associates of West LA in Santa Monica, United States.

Transcranial Focused Ultrasound

Focused Ultrasound

Recruiting1 award2 criteria
This trial is testing a treatment that uses sound waves aimed at specific brain areas to help patients with memory and cognitive issues. The goal is to see if this method is safe and effective for people with mild cognitive impairment or dementia. The therapy has been shown to be effective and safe in animal models of Alzheimer's disease and vascular dementia, with previous trials indicating a tendency to suppress cognitive impairment.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.